CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $96,431
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$96,431. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-12-08 | MORGES WAYNE SVP, Reg. Affairs & Quality | Grant or award · Stock options (right to buy) | +167,096 | 167,096 | ||
| 2014-01-29 | MORGES WAYNE SVP, Regulatory Affairs & Qual | Grant or award · Stock Option (right to buy) | +190,000 | 190,000 | ||
| 2010-05-06 | MORGES WAYNE VP, Regulatory Affairs & Qual | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2010-01-21 | MORGES WAYNE VP, Regulatory Affairs & Qual | Shares withheld for taxes | −2,559 | $1.73 | $4K | 35,532 |
Page 1 of 1 · 4 trades